Vancouver-based
Zenabis Global Inc. (TSX-V.ZENA) has announced that its Maltese joint venture – ZenPharm Limited – has received its Licence for the Production of Cannabis for Medicinal and Research Purposes issued by the Malta Medicines Authority, as afforded under Chapter 578 of the laws of Malta.
Shai Altman, Chief Executive Officer of Zenabis, commented:
“This license is a milestone that marks the beginning of a new chapter for Zenabis and ZenPharm in securing access to the European market. It builds on the dedicated hard work of our Zenabis employees and of our partners at ZenPharm in achieving EU-GMP certification – a journey that we as a company embarked upon solely in anticipation of this moment. I would like to congratulate ZenPharm management and employees for achieving this incredible milestone"
For full details. click
here.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.